Pirfenidone: A novel hypothetical treatment for COVID-19
| dc.creator | Seifirad, Soroush | |
| dc.date.accessioned | 2020-07-15T20:46:20Z | |
| dc.date.available | 2020-07-15T20:46:20Z | |
| dc.date.created | 2020-11 | |
| dc.description.abstractenglish | Cytokine storm, multiorgan failure, and particularly acute respiratory distress syndrome (ARDS) is the leading cause of mortality and morbidity in patients with COVID-19. A fulminant ARDS kills the majority of COVID-19 victims. Pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), is a novel anti-fibrotic agent with trivial adverse effects. Pirfenidone is approved for the treatment of Idiopathic Pulmonary Fibrosis (IPF) for patients with mild to moderate disease. Pirfenidone could inhibit apoptosis, downregulate ACE receptors expression, decrease inflammation by several mechanisms and ameliorate oxidative stress and hence protect pneumocytes and other cells from COVID-19 invasion and cytokine storm simultaneously. Based on the pirfenidone mechanism of action and the known pathophysiology of COVID-19, I believe that pirfenidone has the potential for the treatment of COVID-19 patients. | spa |
| dc.format.extent | 5 páginas | spa |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.doi | https://doi.org/10.1016/j.mehy.2020.110005 | spa |
| dc.identifier.issn | 0306-9877 | spa |
| dc.identifier.other | https://www.sciencedirect.com/science/article/pii/S0306987720308380?via%3Dihub#kg010 | spa |
| dc.identifier.uri | https://hdl.handle.net/20.500.12010/10600 | |
| dc.publisher | Science Direct | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.source | reponame:Expeditio Repositorio Institucional UJTL | spa |
| dc.source | instname:Universidad de Bogotá Jorge Tadeo Lozano | spa |
| dc.subject | Pirfenidona | spa |
| dc.subject | Tormenta de citoquinas | spa |
| dc.subject.keyword | COVID-19 | spa |
| dc.subject.keyword | Pirfenidone | spa |
| dc.subject.keyword | Treatment | spa |
| dc.subject.keyword | Cytokine storm | spa |
| dc.subject.keyword | Oxidative stress | spa |
| dc.subject.keyword | Inflammation | spa |
| dc.subject.keyword | Angiotensin converting enzyme receptor | spa |
| dc.subject.keyword | Acute respiratory distress syndrome | spa |
| dc.subject.lemb | Síndrome respiratorio agudo grave | spa |
| dc.subject.lemb | COVID-19 | spa |
| dc.subject.lemb | SARS-CoV-2 | spa |
| dc.subject.lemb | Coronavirus | spa |
| dc.title | Pirfenidone: A novel hypothetical treatment for COVID-19 | spa |
| dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | spa |
| dc.type.local | Artículo | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Pirfenidone--A-novel-hypothetical-treatment-for-COVID_2020_Medical-Hypothese.pdf
- Tamaño:
- 423.65 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
- Documento reservado
Bloque de licencias
1 - 1 de 1
Cargando...
- Nombre:
- license.txt
- Tamaño:
- 2.87 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: